Keywords
Maternity care, Neonatal care, Independent Advocate, Evaluation, Mixed-methods, Study protocol, Adverse events, Incident reviews, Maternity safety, Healthcare safety
This article is included in the University College London collection.
Recent reviews and research into maternity services have highlighted the need for improved safety and quality of maternity and neonatal care. Systemic failures and safety incidents have resulted in avoidable adverse outcomes for mothers and babies (e.g., stillbirth, neonatal death, or serious injury). The Ockenden review (2022) emphasised the need for women and families to be listened to, heard, and have their concerns acted upon. Ockenden’s recommendation led to the development of the Maternity and Neonatal Senior Independent Advocate (MNISA) role. There is no published evidence on the stakeholder views and experiences, impacts, and costs of the role.
This mixed-methods rapid evaluation aimed to evaluate the implementation of the MNISA role in 16 Integrated Care Boards (ICBs) in England.
To evaluate implementation, experience, and (in) equities relating to the service, we conducted interviews with families who had received support (n=35) and had not received support (n=5), national stakeholders (n=8), MNISAs (n=20), and wider staff (n=30), and held a workshop with MNISAs. Qualitative data was analysed rapidly (using inductive thematic analysis and rapid assessment procedures) and in-depth (using deductive thematic analysis). We also conducted a documentary analysis of relevant national and local documentation.
To evaluate workload, cost of services, and (in) equities in access, we analysed bespoke service data and compared them with relevant national data. We made recommendations for future quantitative evaluations of impact. Qualitative and quantitative analyses were triangulated.
Three of our project’s core team members are public contributors. We also held a Patient and Public Involvement Engagement (PPIE) workshop in July 2024 to discuss project design and plans, and further workshops were planned.
findings helped influence policymaking decisions, particularly regarding whether and how the role will be implemented in the future.
This study was registered in the Research Registry (10760).
Maternity care, Neonatal care, Independent Advocate, Evaluation, Mixed-methods, Study protocol, Adverse events, Incident reviews, Maternity safety, Healthcare safety
Within the NHS in England, many independent reviews into maternity and neonatal care have taken place in recent years (e.g.,1–4), and policy reports5–8 have highlighted criticisms and systemic failings in maternity and neonatal care that have led to, and continue to lead to, avoidable harm and unresolved safety issues. These Inquiries took place due to families having sustained avoidable loss and harm, highlighting safety issues, refusing to accept what they had been told, and campaigning for transparency and change.1–3 Additionally, evidence indicates that safety events resulting in serious incidents (i.e., serious harm or death9) are particularly evident in maternity and neonatal services,10,11 with devastating outcomes for families and staff.12 Reviews in England, together with previous international evidence, indicate a need to improve the safety and quality of maternity and neonatal care in the NHS in England1–8 and worldwide.13–17
Adverse outcomes within maternity and neonatal services can have both physical and psychological impacts on women, birthing people and families.18–21 Maternal adverse outcomes include maternal deaths and severe maternal morbidity, including postpartum haemorrhage,13,14,22–24 hysterectomies, multiple organ dysfunction, and Intensive Care Unit admission.10 Neonatal adverse outcomes include perinatal mortality, stillbirths, and early neonatal deaths,1,2,10 and severe neonatal morbidity, including hypoxic ischaemic encephalopathy (brain injury),1,2 cerebral palsy,10 brachial plexus injury,10 and shoulder dystocia10 (see Table 1 for recent statistics). Evidence has highlighted inequalities (e.g., ethnicity and deprivation) related to maternal and neonatal adverse outcomes.5,15,25,26
Type of adverse outcome | Adverse outcome | Statistic Reference |
---|---|---|
Maternal | Maternal mortality1 | 272 in the United Kingdom from direct or indirect causes from 2020 to 202266 |
Admission to critical care from obstetrics | 1,485 in England 2022-2367 | |
Neonatal | Stillbirth2 | 2,276 in England in 202268 |
Neonatal mortality3 | 1,683 in England in 202268 | |
Hypoxic brain injury | About 1,155 in England in 2022-2369 |
1 Defined as: “Death while pregnant or within 42 days of the end of pregnancy, from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes”5 (page 4). Mortality may be directly related to pregnancy, labour or postnatal complications (<42 days) or indirectly resulting from existing conditions or conditions that developed during pregnancy.5
2 Defined as: “the death of a baby after 24 weeks of pregnancy before or during birth”5 (page 4); and can occur prior to labour (antepartum stillbirth), or at the time of birth (intrapartum stillbirth).5
3 Defined as: “the death of a live born baby in the first 28 days of life”5 (page 4).
Internationally, there have been many strategies to improve maternity and neonatal care (e.g.17,25,27 Some evaluations have focused on workforce strategies, including maternity care coordinators,28 midwife continuity,29,30 postpartum patient navigators,31 perinatal palliative care coordinators32 in America, and the freedom to speak up guardians in the NHS in England.33 Within the NHS, several policy initiatives in recent years have aimed to improve the safety of healthcare services more broadly (discussed and evaluated in34). Other initiatives include the Maternity and Neonatal Safety Improvement programme35 (which aims to reduce rates of maternal and neonatal deaths, stillbirths, and brain injuries by 50% by 2025, in line with the ambitions outlined in the NHS Long term plan36). Furthermore, previous research has outlined the maternity safety frameworks.37
The processes, pathways, and reporting requirements (locally, regionally, and nationally) vary according to the adverse outcomes. These processes include reviews by Maternity and Neonatal Safety Investigation (MNSI, formerly Healthcare Safety Investigation Branch [HSIB]),38 recording of information on the MBBRACE (Mothers and Babies: Reducing Risk through Audit and Confidential Enquiries) UK reporting system,39 the Perinatal Mortality Review Tool (PMRT),40 the Child Death Overview Panel (CDOP),41 and application of the Patient Safety Incident Response Framework (PSIRF).42
Despite these initiatives, adverse outcomes continue to occur3,27; some of which have been demonstrated to be preventable.5,43 Avoidable adverse outcomes linked to recognised safety issues have led to large scale harm caused to families receiving maternity care. This is evidenced by reports that have outlined the scale of litigation and total litigation costs related to obstetric and maternity care.12,44,45 For example, in 2023/2024, NHS Resolution report that £1.15 billion payments were made for maternity-related litigation, which accounted for 41% of overall clinical negligence claims.44,45
Previous research indicates that numerous systemic, organisational, individual, and societal factors may contribute to adverse outcomes within maternity and neonatal services and pathways received by families who have experienced such outcomes. Systemic factors include wider NHS structural changes and budget cuts leading to underfunded maternity services and workforce shortages46 and inconsistent governance processes for reporting, investigating and learning from adverse outcomes.1,2,46 Organisational factors include high turnover and lack of continuity of leadership/management,1,2,47 lack of multidisciplinary collaboration1,2,10,48–51 and staffing and resource issues.47,50–53 Individual factors include: staff factors such as training and skill gaps1,2,47,50 and not listening to women and families.1,2 Societal factors include: increasing social and medical complexities of those going through pregnancy which may affect the management of pregnancies.11,47 Some of these factors have contributed towards women, birthing people and families feeling ignored.1,2,11 Furthermore, they have contributed to families feeling concerned that adverse outcomes have not received appropriate, transparent, full, and inclusive, investigation, and that families have not been given meaningful or appropriate explanations when adverse outcomes have occurred.8,9 There are many benefits of involving parents in reviews of adverse outcomes and healthcare harm events more broadly, and findings indicate that parents want to be included (with the proviso of sensitive, compassionate and open and honest communication).43 However, findings from previous research have highlighted that many review processes and inquiries in the maternity and neonatal space may not inform families about investigations taking place54 and that review processes often do not include families.43,54 The Ockenden review of maternity services at Shrewsbury and Telford Hospital NHS Trust (2022) outlined several Immediate and Essential Actions to improve maternity and neonatal care.1,2 One Immediate and Essential Action (IEA) specified that “Maternity services must ensure that women and their families are listened to with their voices heard”, and that “Trusts must create an independent senior advocate role”.1,2
In response to this recommendation, NHS England developed the Maternity and Neonatal Senior Independent Advocate (MNISA) role.55,56 This role is currently being piloted in England across 16 Integrated Care Boards.55,56 The MNISA role was developed and introduced into ICBs by NHS England in May 2023, with operational guidance for the role published in November 2023. The first MNISAs started working with their families in January 2024. MNISAs were employed to fit a nationally specified job description that was intended to enable them to deliver the role and its dual purpose (listening to women and families and supporting change). MNISAs may be employed within ICBs or external organisations. MNISAs receive standardised training prior to the start of the role.
The role of MNISAs is intended to support and advocate for women and families who have experienced an identifiable adverse outcome, so that they are listened to, heard, and their feedback is used to bring forward change to help make maternity care better and safer. The role aims to help women and families to navigate processes and systems, and signpost them to further services as appropriate and advocate for learning and change.56 The adverse outcomes included within the scope of this role for the initial pilot phase are: i) Stillbirth (after 24 weeks of pregnancy), ii) neonatal death, iii) maternal death, iv) unplanned or unexpected hysterectomy (within 6 weeks of birth), v) maternal admission to critical/intensive care and vi) neonatal brain injury that has been diagnosed or suspected, including hypoxic-ischaemic encephalopathy (HIE).56
As this is a new role, there is currently no published evidence on how it is viewed by different stakeholders (including families), how much it costs, or its perceived impact. Therefore, a mixed-methods evaluation is needed to evaluate the impact, cost, and stakeholder experience from different perspectives.
This study aims to rapidly evaluate the pilot implementation of the Maternity and Neonatal Independent Senior Advocate (MNISA) role in England. This study answered a range of research questions (see Table 2).
This study is a collaboration between researchers from the NIHR RSET,57 Rapid Service Evaluation Team (RSET) public contributors, and Sands. Sands58 is a third-sector organisation that works to support those affected by pregnancy loss or the death of a baby and to prevent future deaths. Sands will collaborate on this study and will be closely involved in the design of the study, data collection, analysis (together with the research team), and writing.
This study was reviewed and given a favourable opinion by the NHS East of England – Cambridgeshire and Hertfordshire Research Ethics Committee [REC reference: 24/EE/0205] and received Health Research Authority approval. The protocol was peer reviewed by two reviewers external to UCL.
To ensure the appropriate support and safeguarding of participants in this study, we used safeguarding and distress protocols developed specifically for this study (see Figure 2 for a summary of safeguarding and distress protocols).
Data was managed in line with legal and regulatory requirements, including the General Data Protection Regulation (GDPR), the Data Protection Act (2018), and necessary research approvals.
The research team met every two weeks to discuss the project progress. The project leads (HW/NC/JS) also reported regularly on progress to the wider RSET57 Executive Management group.
We set up an independent project advisory group to provide independent advice, governance, and feedback on the project at all stages. This group includes a wide range of stakeholders, including those within maternity and neonatal organisations (system level, regional level), regulatory bodies, third-sector organisations, professional bodies, clinicians, and academics. We met with this group 2-3 times during the project.
Our project team includes three PPIE contributors (RM, SF, and CM), who have actively been engaged in weekly, and more recently, bi-weekly, project team meetings, and wider meetings to discuss and develop the study and provide written input intermittently. They will continue to attend meetings and contribute to all aspects of the study (including interpretation, write-up, and dissemination of findings). We also sought feedback from NHSE service user representatives on the study design and development.
Additionally, we held a wider PPIE workshop with five members of the public who had experienced adverse outcomes within their maternity or neonatal journey and/or investigation and complaint procedures. This workshop focused on the study of data collection tools and safeguarding processes. We held wider PPIE workshops to inform the key stages of the project, such as findings and dissemination.
Feedback from our PPIE contributors had informed many changes to our study including ‘thank you’ vouchers for family participants, expanding the type of interviewees included in the study, data sources, and considerations relating to equity, diversity and inclusion. PPIE contributors provided lived experience insight into the process’ navigated by families after an adverse event and the identification of relevant stakeholders. PPIE input has provided a more diverse recruitment strategy for interviewees and has enhanced the tailoring of support for those families who seek to engage in the study, offering more flexible and inclusive interview and submission options for families (including the option to input via verbal interview, writing, or a combination of both). The PPIE feedback and outcomes were recorded using a PPIE study log. PPIE contributors were supported throughout the study by PPIE leads (PLN, RM) and project leads (NC, HW, JS) to ensure that any needs and/or preferences were considered.
We applied the NIHR Rapid Service Evaluation Team (RSET) EDI project-specific assessment tool at three stages during this project: (i) during the development of the project evaluation, (ii) during data collection and analysis, and iii) following data collection and analysis. The assessment tool covered EDI considerations throughout the entire project, including when building the initial team, drawing on published EDI frameworks to consider EDI aspects relevant to the evaluation during the discovery and scoping phases, protocol development, stakeholder engagement, recruitment, data collection, data analysis, and dissemination. The study team met every six weeks to discuss and review EDI progress.
To ensure that our project thoroughly considered issues of EDI, we held several broad scoping conversations with stakeholders (such as policymakers, third sector organisations, clinicians, professional and regulatory bodies, and academics) to identify potential areas of inequity that may exist within this role in relation to the service. These conversations highlight that some groups of parents were more likely to experience adverse outcomes due to ethnicity and deprivation-related characteristics. This highlights the need to ensure that we considered within this evaluation whether the service reached those groups, potential barriers, and how they experienced the service.
We considered research questions related to EDI (see Table 2). We took steps to encourage diverse public voices to participate as PPIE contributors throughout this study. We also discussed with stakeholders how to best develop a recruitment strategy, data collection materials, data collection, and data analysis processes that will enable a wide range of families to participate in this evaluation.
This was a rapid mixed-methods study combining qualitative (workstreams 1-3), quantitative and health economic approaches (workstream 4) to evaluate the implementation of MNISAs in England. An integration workstream (5) brings together the qualitative and quantitative findings (see Figure 1 for a summary).
Aims
Within these qualitative workstreams, we aimed to evaluate: i) family experience of the MNISA service (including those who have received and those who were eligible to receive but have not received support), ii) service development and implementation, and iii) staff experience of the MNISA role (including MNISAs and wider staff ).
Design
Qualitative design, comprising semi-structured interviews, documentary analysis and workshops.
Sample
Site sample and recruitment.
The MNISA role was piloted in 16 Integrated Care Boards (ICBs) in England. All 16 ICBs were invited to participate in this study. All 16 ICBs were included in the study (family and MNISA interviews). Additionally, 10 of the 16 ICBs were selected as in-depth case study sites (family, MNISA, and wider staff interviews). We purposively sampled these case study ICBs to ensure their representation with a range of characteristics, such as the model of MNISA employment used in that area (e.g., ICB employed or external organisation employed), geographical area, single/multi-trust ICB, time since implementation, and level of oversight/engagement from the ICB.
Individual sample
Please see Table 3 for a summary of our sample, and eligibility criteria.
Work streama | Activity | Who we will invite to take part | Eligibility criteria | Recruitment process | Who will conduct/facilitate | Approx. time | Recruitment study months |
---|---|---|---|---|---|---|---|
1 | Interviews with families (parents/guardians/next of kin) who received service | We will aim to speak with 15-35 families (parents/guardians/next of kin) from a range of backgrounds, who have received support from a Maternity and Neonatal Independent Senior Advocate |
|
| Facilitated by one Sands researcher (JH, BW) and one RSET researcher (HW/NC/RL/NH)b,c | 30-60 minutes | October 2024-April 2025 |
Interviews with families who are eligible to receive support but have not accessed support from MNISAs | We will aim to speak with 3-5 parents/guardians from a range of backgrounds, are eligible, but who have not received support from a Maternity and Neonatal Independent Senior advocate |
| Facilitated by one Sands researcher (JH, BW) and one RSET researcher (HW/NC/RL/NH)d | 30-60 minutes | October 2024-April 2025 | ||
2 | Documentary analysis | We will identify relevant national documents pertaining to the MNISA role and implementation (e.g. operational guidance, communications toolkit, training materials) |
|
| NC/HW/RL/NH | N/A | October 2024 – March 2025 |
Interviews with national stakeholders | We will aim to speak with 3-8 national level stakeholders (including policy makers, service developers, MNISA service steering group members, charities, other relevant organisations) |
|
| NC/HW/RL/NH | 30-60 minutes | October 2024-April 2025 | |
3 | Documentary analysis | We will identify relevant local level documents pertaining to the MNISA role and implementation (e.g. training materials, standard operating procedures, job descriptions) |
|
| NC/HW/RL/NH | N/A | October 2024 – March 2025 |
Interviews with MNISAs | We will aim to speak with 15-20 Maternity and Neonatal Independent Senior Advocates. We will ask all MNISAs to complete a short survey prior to interviews to provide some details about their role and demographics. As we may not be able to recruit all MNISAs to take part, we will purposively select MNISAs to ensure representation from individuals with a wide range of characteristics, including: the model of MNISA employment (e.g., ICB or external organisation), geographical area, time since implementation, background of the MNISA (e.g., clinical vs non-clinical) and type of contract (e.g., fixed-term or zero hours). |
|
| NC/HW/RL/NH | 30-60 minutes | October 2024-April 2025 | |
Workshop with MNISAs | We will aim to conduct one in person workshop with Maternity and Neonatal Independent Senior Advocates. |
| NC/HW/RL/NH | 90-120 minutes | January 2025 | ||
Interviews with wider staff (network level, Integrated Care Board level and trust level staff) | We will aim to speak with up to staff from 8-10 Integrated Care Board areas. This will include ICB level staff and trust level staff and network or regional level staff. |
|
| NC/HW/RL/NH | 30-60 minutes | October 2024-April 2025 |
a For details of which research questions are covered within each workstream, please see Table 2.
b If preferred, families will be offered a written or hybrid option to share information (i.e. to provide some responses in writing before or after the interview).
For the family interviews, we aimed to conduct interviews with 15-35 parents and/or guardians who had received support from a MNISA and up to five interviews with parents and/or guardians who would have been eligible for support from a MNISA but had not received or accessed the service. While we aimed to recruit 40 families with diverse characteristics, recruitment was dependent on several factors, including the number of families and the diversity of families who had accessed the service (due to the infancy of the service) and the number of families who were willing to be interviewed. We aimed to purposively sample families across a range of characteristics, including the range of adverse outcomes experienced, family role (e.g., mother, father, or other guardian), age, geographical area (to cover the range of ICBs included in the pilot), ethnicity, length of time engaging with the MNISA, stage in their journey following the outcome, disability, and sexuality (see Table 3 for details of eligibility criteria).
For the staff interviews, we aimed to conduct: i) interviews with 3-8 national stakeholders (e.g., those working in policy roles, commissioning roles (including at ICB’s who initially signed up for the pilot but did not continue to implement the role), programme leads, regulatory roles (e.g., CQC), public inquiry and review teams, professional organisations, third sector organisations, and training organisations), ii) individual interviews and a workshop with up to 20 MNISAs from the 16 ICBs (currently or previously in post), and iii) interviews with up to 30 staff who work with MNISAs from the 10 case study ICBs (up to three staff per ICB, spanning network/regional level, ICB level, and trust level staff ). For the wider staff interviews, flexibility in the sampling approach was informed by scoping work, which indicated that those best placed to discuss the MNISA’s role will vary across ICBs. Network or regional level staff roles included operational delivery network staff, local maternity and neonatal system staff, maternity and neonatal safety investigation staff, and child death overview panel members. ICB level staff included line managers and maternity and neonatal voice partnerships (MNVPs). Trust level staff included those involved in developing local policy, midwives, nurses, bereavement teams, medical examiners, family liaison coordinators, those dealing with maternity and neonatal complaints, or those involved with incident reporting processes.
For the documentary analysis, we sampled relevant national and local documents pertaining to the role and implementation (e.g. operational guidance, communications toolkit, relevant reports relating to the set-up/design of the role, and training materials).
Recruitment
See Table 3 for a summary of our recruitment processes.
For the family interviews, participants were identified using a range of different recruitment processes, including identification through the participating 16 ICBs, and recruitment via social media and third sector or advocacy organizations.
Families (individuals or dyads, e.g., both parents) who were interested in participating in the evaluation were asked to contact the researchers via email or telephone. After this initial point of contact, the researchers (NC/HW/RL/NH) asked some basic eligibility questions (whether they had received support from a MNISA, which ICB they were in, and whether they were over the age of 18) and provided an information sheet and consent forms. We offered the option for information sheets and consent forms to be translated if needed. Potential interviewees were informed that their participation is completely voluntary. If interviewees were interested in participating, they were asked to provide electronic, written, or audio-recorded verbal informed consent prior to participating in the interview. Prior to the interview, the participants were asked to complete a short socio-demographic survey.
Staff interviews (MNISAs, wider staff, national stakeholders):
For national stakeholder interviews, researchers (NC/HW/RL/NH) identified relevant organisations or job types that may have a view of the MNISA role. Researchers emailed these organisations to ask for expressions of interest from their organisation/team in taking part in an interview.
For MNISA and wider staff interviews, researchers (NC/HW/RL/NH) identified relevant organisations, teams, and job roles and emailed a point of contact for these organisations, teams, and job roles to ask them to share details of the study recruitment with relevant members of their teams. Additionally, staff may cascade the details of the study with other staff members who they think would be eligible/interested in. Interested individuals were asked to contact the researchers to express their interest in participating.
For all staff interviews, researchers sent information sheets and consent forms to those who express interest. Potential interviewees were informed that their participation is voluntary. If interviewees were interested in participating, they were asked to provide electronic, written, or audio-recorded verbal informed consent prior to participating in the interview.
MNISA workshop:
For the workshop (MNISAs), researchers emailed all MNISAs to check whether they would be happy to participate in a workshop for the study. MNISAs were sent an information sheet and consent form in advance and asked to provide electronic or written consent before the workshop.
Measures
To ensure sensitivity, appropriateness, and comprehensiveness, semi-structured interviews and workshop topic guides were developed for this study, following conversations with relevant stakeholders during scoping, input from our patients and public involvement members, and input from Sands. (see Table 4 for a summary of topics covered.)
Prior to the interviews, all participants were asked to complete a sociodemographic questionnaire. For families, this included gender, age, sexual orientation, area of the UK in which they live, ethnicity, first language, relationship status, and category of adverse outcomes. For MNISAs, this included their employer, previous experience/background (e.g., clinical/non-clinical), training received, number of families working with, length of time in the role, type of contract (e.g., fixed term or zero hours), length of time working with families, whether they think the role is meeting NHS England’s objectives, and whether they had seen change at individual or organisational levels (and to provide examples). For wider staff and national stakeholders, this included the role and length of time in the role.
Data collection
Family interviews:
All participants were offered the option to participate in the interview on their own or with a family member (either in a joint or separate interview). Participants were offered the option to participate in the interview online (via MS Teams), over the telephone, or via a written response via a secure electronic survey link (REDCap). The written response option is consistent with similar projects that have offered alternative methods of interview participation.59 Interviews were scheduled at a time of day which was agreed upon by the participants. If English was not a participant’s first language, we offered interpretation services so that they could participate in the interview. Each interview was jointly facilitated by a researcher from Sands (JH) and a researcher from RSET (NC/HW/RL/NH). Participants were informed of the interview arrangements prior to the interview, and the arrangements were flexed according to preferences. We offered participants the option to have an informal call with the researchers prior to the formal interview to provide an opportunity for them to share their experiences and events leading to the adverse outcome (should they wish to). This lasted between 20-30 minutes and was not part of the formal data collection, and not recorded. The formal interview, which focused on the experience of the MNISA role, lasted between 45-60 minutes and was recorded. However, if participants chose not to have two separate conversations, we explained to them that interviews would take between 30-90 minutes depending on how much they would like to say. Any interview responses via an electronic survey were directly returned to the study team for analysis electronically through REDCap. Participants were informed that they are free to withdraw for up to two weeks after the interview date. If families would like to provide further information following an interview, we offered them a short follow-up interview or gave them the option of adding any additional information via a secure electronic survey link.
As a thank you for participating in the interview, the families were given a one-off £25 voucher. This was deemed appropriate following the feedback from our PPIE contributors.
As the interviews involved family members potentially discussing distressing and/or traumatic events and adverse outcomes, we implemented several data collection protocols to support and safeguard families (see Figure 2 for a summary of our safeguarding and distress protocols).
Staff interviews (MNISAs, wider staff, national stakeholders):
The interviews were conducted either online or over the telephone. Each interview lasted between 60-90 minutes. Interviews were scheduled to take place during regular working hours, as staff were not being compensated for their study participation.
All interviews:
If interviewees (family, MNISA staff, or wider stakeholders) wanted to provide further information following the interview, they could send further feedback in writing, or researchers would arrange a short follow-up interview. Participants were informed that they were free to withdraw for up to two weeks after the interview date.
Data collection protocols were implemented to support the staff participating in the study (see Figure 2).
MNISA workshop:
The in-person workshop lasted between 90 minutes and 2 hours. Researchers took detailed notes during the workshop to capture the key findings. Participants were informed that while they can withdraw from the discussion, any data provided until that point would be retained, as it would not be possible to remove individual data from a group discussion.
All interviews and workshops were audio-recorded on an encrypted Dictaphone (subject to consent), transcribed verbatim by a professional transcription service, anonymised, and kept in compliance with the General Data Protection Regulation (GDPR, 2018) and Data Protection Act (2018). The data are stored securely on the UCL Data Safe Haven. Only named researchers have access to participants’ personal data.
Data analysis
We used a medium Q thematic analysis approach,60 combining inductive thematic analysis and the use of a coding framework.61 Data collection and analysis was carried out in parallel using Rapid Assessment Procedure (RAP) sheets.62 Qualitative data was be analysed by named researchers in the Rapid Service Evaluation Team (HW/RL/NC/NH) and Sands (JH/BW). Researchers conducting interviews would take real-time notes and input them into Rapid Assessment Procedure sheets following each interview. The categories used in the RAP sheet were based on interview topic guides. There was flexibility in adding categories during the research process. Once notes have been input into the RAP sheets, researchers will use inductive thematic analysis61 to inductively code these notes and develop initial themes and sub-themes. This rapid analysis was used to share interim findings with key stakeholders throughout the study. Following this rapid analysis, an in-depth analysis was conducted. Researchers used the initial themes and sub-themes developed during rapid analysis to develop a coding framework. This coding framework was applied to interview transcripts. Coding will be used to develop the final themes and sub-themes relating to the research questions.
We aimed to undertake cross-case comparisons across different ICBs and different characteristics (e.g., to explore barriers/inequities relating to access, use, and experience). Interpretation of findings and write-up will be discussed and agreed with the study’s PPIE group, advisory group, and project team prior to finalising.
Theoretical frameworks for the implementation of healthcare services/innovations were considered to align with the workstream research questions and objectives prior to data collection and analysis to guide the evaluation. Examples of frameworks that were considered include RE-AIM63 (a framework that includes five key outcomes: reach, effectiveness, adoption, implementation, and maintenance) and CFIR64 (Consolidated Framework for Implementation Research).
Aims
This workstream aimed to explore the potential impacts and cost of the MNISA role and make recommendations about data capture and analysis for future evaluation (see Table 2 for the research questions).
Design
An observational study of MNISA caseload data, national electronic health records, other secondary data sources, and findings from qualitative interviews and workshops (see workstreams 1-3). The health economic study evaluated the financial impact of the existing pilot programme for MNISA support of families who have experienced eligible adverse outcomes from maternity and neonatal health services, and to explore the cost implications of a wider roll-out of the programme, changes in the eligibility criteria for MNISA support, and scenarios on the impact of MNISA support on patient safety.
Sample
All cases were supported by MNISA’s that are reported in the bespoke NHSE data collection compared to cases reported in hospital records (Hospital Episode Statistics) or other relevant datasets.
Measures
1) Case volume according to ICB and adverse events. Other possible disaggregation’s by trust, ethnicity, deprivation, referral source, and quarter.
2) Case volumes as specified in 1), alongside potential case volumes identified in routine hospital data (HES) and other maternal/neonatal data.
3) Measures of parent/family benefits were identified through interviews with stakeholders and workshops.
4) NHSE and ICB-level MNISA service resource use and cost data (total and disaggregated by category).
5) NHSE case litigation data for eligible adverse events, disaggregated by event type.
Potential data sources and their purposes are described in Table 5.
Data source | Purpose |
---|---|
NHSE bespoke MNISA caseload data | Providing descriptions of the caseload data in terms of source of case and case-mix. For understanding any inequalities or biases in caseloads when compared with volumes of adverse events reported in other data sources (see below). |
Hospital Episode Statistics (HES) | To estimate the total case-mix of mothers/babies experiencing four out of the six adverse events. To be used as a baseline for comparing with MNISA caseloads. |
Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK. (MBRRACE-UK) | To estimate the total case-mix of maternal deaths and neonatal deaths and stillbirths. To be used as a baseline for comparing with MNISA caseloads. Can also be used to validate equivalent information from HES. |
Cost data from NHSE and ICBs | To estimate total costs (NHSE pilot funding data), for implementation of the MNISA support services and breakdown cost by category (e.g., MNISA staff costs, administrative support, travel, IT and other relevant resources) for participant ICBs. |
Information from qualitative interviews and workshop (see WS1-3) | To identify relevant perspectives on:
|
NHS costs data (e.g., PSSRU: Unit costs of health and social care, NHS England: National schedule of NHS costs), and costs data for relevant investigations (MNSI/HSIB, coroner) | To inform cost estimates for relevant health care service activities resulting from eligible adverse outcomes and associated post-event investigations. |
Published literature on the economic impact of eligible adverse outcomes (e.g.70,71) | These data will inform the modelling (from an NHS and PSS perspective) of potential cost benefits through cases of harm avoided as a consequence of MNISA support enabling safety improvements through system change. These data will also inform consideration of the wider (societal) economic impacts of eligible adverse outcomes, and the potential benefits of cases of harm avoided through MNISA support. |
Relevant NHSE case litigation data (Potential source: NHS resolution), covering case numbers and aggregate costs (legal representation/pay-outs/other associated costs (including staff hours, and number of staff involved) | To estimate NHSE litigation caseloads and (mean) litigation cost estimates (legal representation, settlements with or without damages), by category of harm. These data will inform the modelling of potential cost benefits through cases of harm avoided as a consequence of MNISA support enabling safety improvements through system change. |
Data analysis
Findings from workstream 1-3 were used to inform the qualitative impacts of the MNISA role on individuals, organisations, and systems (including views on safety and quality improvement).
To review the current operation of MNISAs and variations between ICBs and trusts (e.g., caseload, case type), we conducted a descriptive analysis of the bespoke MNISA caseload data collected by NHS England.
Equity of access to support was estimated using electronic health data. To do this, we compared the case mix of individuals experiencing adverse events from hospital records with the data collected by the pilot on individuals who are supported. Appropriate modes of analysis were used to investigate the relationship between patient factors such as ethnicity and support for eligible parents/families.
Identifying differences between actual and potential caseloads were carried out using multivariate analysis, comparing hospital records with data collected by the pilot. We aimed to analyse differences in the number of adverse events between ICBs.
To analyse the implications of rolling out the role to cover a wider range of adverse events, we carried out a similar analysis for each proposed additional event.
Short-term costs were estimated using publicly available sources of data ( Table 5), including the average costs of the baby/family events and subsequent (HSIB/MNSI, coroner) investigation (these informed the number and type of events, associated resource use, etc.), and unit costs of resources as required by the MNISA in their provision of support (e.g., support and advice service consultations as provided via the Personalised Care and Support Plan). An in-depth analysis of the costs and potential benefits of the MNISA program were conducted using the logic model developed in Workstream 5. From this, an economic model for the current MNISA program was developed to quantify costs for the current MNISA program, including healthcare costs associated with the adverse outcomes, associated litigation costs (e.g., legal representation and pay-outs) and long-term consequences. A sensitivity analysis was performed to address the expected range of uncertainty.
The model was also designed to explore the costs and consequences of scenarios for the rollout (in terms of staff numbers, expansion of MNISA role/workload, addressing barriers or inequalities in accessing MNISA support, and the timing of program expansion) of the MNISA programme.
Recommendations about data capture and analysis for future evaluation were derived by assimilating information gathered from interviews and workshops already planned for workstreams 1-3. To this end, appropriate questions were added to the topic guides developed for these interviews.
All the workstreams (1-4) inform each other. The collected data and findings were triangulated.65 The mixed-methods approach will be beneficial as it will ensure rigor and allowed the team to consider research question findings from multiple perspectives in depth. For example, qualitative findings related to potential strategies to overcome inequities or gaps in service delivery in terms of inequities were triangulated with quantitative findings regarding access to the service and potential inequities. Additionally, findings on the potential benefits and risks of the role identified through qualitative workstreams could be used to inform quantitative and cost exploration. As part of the integration, we aimed to develop a logic model of the MNISA service (which outlines the implementation, potential mechanisms of change, and potential outcomes and costs). We also developed recommendations for improving and evaluating this service in the future. We worked together through regular project team meetings and the regular sharing of findings from each workstream.
Study development (including ethical approval) took place between April and October 2024. Data collection and analysis took place between October 2024-June 2025. The study’s final report and dissemination outputs were submitted from June 2025 onwards.
We will disseminate findings in several ways, including:
• Presenting findings at conferences.
• Publishing findings in peer-reviewed journals.
• Submitting a slide set final report to NHS England to inform future decision making.
• Presenting emerging and final findings regularly with key stakeholders (e.g., NHSE programme leads, Integrated Care Boards, our independent advisory group).
• Producing accessible public facing outputs (developed with input from our PPIE contributors, other key stakeholders, and the Nuffield Trust communications team). These included blogs, animations, and infographics.
Findings from the study will be used to develop recommendations for the future implementation of this role and/or similar models that may be implemented in the future in England or other countries.
This protocol outlines our rapid mixed-methods approach, which aims to evaluate the pilot implementation of the Maternity and Neonatal Independent Senior advocate role in England. This research extends previous research (e.g., international and UK research evaluating strategies to improve maternity services generally17,25,27,34–37 and workforce strategies28–33) by providing evidence on the implementation, family and staff experience, and the impact and cost of this role in England.
The strengths of this research include the rapid mixed-methods design, which will enable real-time evidence generation related to implementation, experience, impact, and cost during the pilot of the MNISA role. This will enable triangulation of different aspects of the study to provide meaningful lessons that can be used to optimise service delivery and inform decision-making around the wider applicability of the role in the future.
A further strength of this research is our collaboration with sand and the breadth of stakeholder engagement, which has been used to inform the development of the study design. Through PPIE input, wider stakeholder engagement, and scoping conversations, this has enabled the design of a study that will hopefully be feasible to achieve within the rapid timeframe, but that will also address important questions relating to the evaluation of the pilot.
However, this study has some limitations. Given the rapid timeframe, while we will make every effort to recruit as many diverse views as possible within our study, the success of recruitment will depend on some factors out of the study team’s control (e.g., the service will not have been up and running very long, and some adverse outcomes may be more frequent in certain populations). These examples, together with other factors, may have impacted various aspects of the study. For qualitative workstreams, these factors may impact the number and diversity of families that have received support and/or may wish to take part. Furthermore, we only aimed to interview up to five families that had not received support. For the quantitative workstream, sample sizes within the caseload data may not be sufficiently large to identify many aspects related to inequities. Finally, we acknowledge that the available evidence arising from this evaluation will not include thorough effectiveness and cost findings owing to the timing of the evaluation.
This rapid evaluation of the pilot of the MNISA role in England provides key information regarding the impact and cost implications of the role to date (while acknowledging the short implementation period to date), enabling the development of recommendations for optimising the implementation of this role in the future and enhancing family and staff experience of the service.
If this role is implemented more widely in the future, it is necessary for future research to capture the long-term impact (effectiveness) and cost-effectiveness of the MNISA role. Additionally, further research on implementation, training and development needs, and staff and family experience would help to explore variations in implementation and experiences over time (particularly in relation to inequalities in access to and experiences of the role for families).
This protocol outlines our plans for conducting a rapid mixed-methods evaluation of the pilot of the MNISA role in England. The findings will inform future implementation and provide learning that can be used to improve this service, as well as other similar services that may be implemented in England or internationally.
This study was reviewed and given a favourable opinion by the NHS East of England – Cambridgeshire and Hertfordshire Research Ethics Committee [REC reference: 24/EE/0205] and received Health Research Authority approval.
Informed consent was obtained from all participants before taking part in the study, with different options for consent (written, verbal) provided to ensure that participation was accessible and inclusive. Further details are presented in the Qualitative workstream section of this article.
This is a protocol, therefore no data are associated with this article.
Thank you to all of the stakeholders who have given their time to discuss the evaluation with us, including the project’s public contributors and those taking part in our PPIE workshop. We would also like to thank the NHS England program steering group members who contributed to the design and supported the conduct of the evaluation, as well as the third sector organisations who have contributed through scoping conversations and reviewed our evaluation plans.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)